MeSH tree: C12.200.777.419.473.160
Close to half of America's tap water contains PFAS, or perfluoroalkyl and polyfluoroalkyl substances. These "forever chemicals" are in thousands of products, from clothing and cosmetics to cleaning products, and are linked ...
Jun 12, 2024
0
82
For nearly two decades, how kidney cancer becomes resistant to rapalog drugs has baffled the scientific community. Now a study by researchers at UT Southwestern Medical Center's Kidney Cancer Program sheds light. Published ...
Jun 12, 2024
0
59
Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.
Jun 4, 2024
0
59
Immunotherapy increases survival rates in kidney cancer, but does not work for everyone. A Leuven research team has developed a new method to predict which patients will benefit from it. The team of Francesca Finotello (Computational ...
May 24, 2024
0
68
A novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients according to new research published in the May issue of The Journal of Nuclear Medicine.
May 7, 2024
0
50
A new study led by University of Michigan Health Rogel Cancer Center researchers identifies novel biomarkers in renal cell carcinomas. The researchers' integrative analysis of comprehensive proteogenomic datasets from both ...
May 6, 2024
0
67
Researchers analyzing the DNA of people with kidney cancer worldwide have found evidence of an unknown trigger that could explain the longstanding mystery of why some countries have a higher incidence of the disease.
May 2, 2024
0
61
In a new analysis of genetic susceptibility to kidney cancer, an international team of researchers has identified 50 new areas across the genome that are associated with the risk of developing kidney cancer. These insights ...
Apr 26, 2024
0
66
A cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according to a clinical trial published in the Journal of Clinical Oncology.
Apr 25, 2024
0
60
For the first time in fifty years, results from a Phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.
Apr 17, 2024
0
48
